In a 67-year-old woman with a long-standing recurrent unexplained cough, no smoking history, normal chest imaging, and normal pulmonary function tests, what are the possible causes and recommended treatment options?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Unexplained Chronic Cough: Diagnosis and Treatment

This patient likely has unexplained chronic cough (UCC), and you should offer multimodality speech pathology therapy as first-line treatment, with gabapentin as a second-line option if speech therapy fails or is unavailable.

Diagnostic Approach

Before confirming UCC, you must complete a structured workup to exclude treatable causes 1:

Required Testing

  • Objective testing for bronchial hyperresponsiveness (methacholine challenge) OR therapeutic corticosteroid trial
  • Eosinophilic bronchitis testing: sputum eosinophils or exhaled nitric oxide
  • Ensure previous imaging was adequate (chest x-ray at minimum)

Critical Exclusions

The diagnosis of UCC requires that cough persists >8 weeks and remains unexplained after:

  • Systematic investigation completed
  • Supervised therapeutic trials conducted according to best-practice guidelines
  • Patient adherence to treatment trials confirmed 1

Common pitfall: Many patients are incorrectly labeled as having "unexplained cough" when the actual problem is inadequate investigation or suboptimal treatment trials 2. Before accepting this diagnosis, verify that empiric trials were truly adequate for:

  • Upper airway cough syndrome (postnasal drip)
  • Cough-variant asthma
  • Gastroesophageal reflux disease (if symptoms present)

Treatment Algorithm

First-Line: Speech Pathology Therapy

Recommend multimodality speech pathology-based cough suppression therapy 1. This intervention has demonstrated improvement in cough severity and quality of life with minimal side effects.

Second-Line: Gabapentin

If speech therapy is unavailable or ineffective, offer gabapentin with careful counseling 1:

Dosing regimen:

  • Start: 300 mg once daily
  • Titrate: Add additional daily doses as tolerated
  • Target: Up to 1,800 mg/day in two divided doses (maximum tolerable dose)

Critical counseling points:

  • Discuss potential side effects and risk-benefit profile before starting
  • Reassess risk-benefit at 6 months before continuing 1
  • Gabapentin improves quality of life in randomized trials, which may outweigh side effects given the significant QOL impairment these patients experience

What NOT to Do

Avoid inhaled corticosteroids if testing for bronchial hyperresponsiveness and eosinophilia (sputum eosinophils, exhaled nitric oxide) is negative 1. Grade 2B recommendation against their use in this setting.

Avoid proton pump inhibitors if workup for acid gastroesophageal reflux disease is negative 1. Grade 2C recommendation against empiric PPI therapy without evidence of GERD.

Key Clinical Nuances

Quality of life impact: UCC causes significant impairment in health-related quality of life, often persisting for months to years 1. This justifies more aggressive treatment approaches including gabapentin despite potential side effects.

Prevalence: UCC occurs in 5-10% of patients seeking care for chronic cough and up to 46% of specialty cough clinic referrals 1, so this is not a rare diagnosis when properly evaluated.

Multiple causes: Remember that 20% of chronic cough patients have more than one contributing cause 3. If initial treatment fails, reconsider whether all potential causes were adequately addressed rather than immediately labeling as refractory.

Practical Implementation

For this 67-year-old woman:

  1. Confirm testing for bronchial hyperresponsiveness and eosinophilic bronchitis was completed (or perform therapeutic corticosteroid trial)
  2. If negative, refer to speech pathology for multimodality cough suppression therapy
  3. If speech therapy unavailable or fails after adequate trial, initiate gabapentin 300 mg daily with dose escalation protocol
  4. Schedule 6-month reassessment if using gabapentin
  5. Consider specialty cough clinic referral if both interventions fail 1

Related Questions

In a patient with a normal echocardiogram, chronic cough, dyspnea, burning sensation in the lungs, a history of smoking, and pulmonary function tests showing a mild restrictive pattern, what is the next best treatment plan?
In an otherwise healthy adult without comorbidities, how should a cough that occurs only while sitting on the toilet be evaluated and managed?
A patient has had a chronic cough and cold-like symptoms for 18 months; what is the likely diagnosis and recommended treatment, including specific medication dosages?
Should a cough with a completely normal lung examination be treated as viral?
In a patient receiving methadone linctus (syrup) who develops a persistent cough, how should the cough be evaluated and managed?
How many times per day can I use the Airsupra (albuterol/budesonide) inhaler?
In a patient who was on sertraline 100 mg with a QT interval of 470 ms, which was tapered and discontinued, and now presents with low mood and agitation, what alternative antidepressant medication can be prescribed that does not prolong the QT interval?
What are the recommended guidelines for initiating and titrating antihypertensive therapy in adults, including first-line drug choices and special considerations for diabetes, chronic kidney disease, or heart failure?
What are the diagnostic criteria for overt and subclinical hypothyroidism, including TSH and free T4 thresholds?
What is the most effective drug for anxiety with psychotic features?
Can an 80-year-old patient with a remote history of tuberculosis at age 4 safely use intranasal corticosteroids?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.